

Health Library
October 10, 2025
Question on this topic? Get an instant answer from August.
Adalimumab-adaz is a biosimilar version of the widely-used medication adalimumab, designed to treat various autoimmune conditions by calming your overactive immune system. Think of it as a targeted therapy that helps restore balance when your body's defense system mistakenly attacks healthy tissues.
This medication belongs to a class called TNF blockers, which work by blocking a specific protein that drives inflammation in conditions like rheumatoid arthritis, psoriasis, and inflammatory bowel disease. Understanding how this medication works can help you feel more confident about your treatment journey.
Adalimumab-adaz is a biosimilar medication that mimics the effects of the original adalimumab. A biosimilar is essentially a highly similar version of an already-approved biologic medication, meeting strict safety and effectiveness standards.
This medication is a monoclonal antibody, which means it's a lab-created protein designed to target specific parts of your immune system. It's given as an injection under your skin, usually in your thigh or stomach area, and works by blocking tumor necrosis factor (TNF), a protein that causes inflammation when present in excess.
The "adaz" part of the name helps distinguish this particular biosimilar from other versions of adalimumab on the market. Your doctor may prescribe this instead of the original medication because it offers the same therapeutic benefits, often at a lower cost.
Adalimumab-adaz treats several autoimmune conditions where your immune system attacks healthy tissues. Your doctor might prescribe this medication if you have moderate to severe inflammatory conditions that haven't responded well to other treatments.
Here are the main conditions this medication can help manage, each representing a different way your immune system may be overactive:
Your healthcare provider will determine if this medication is right for your specific condition based on your symptoms, medical history, and how you've responded to other treatments. The goal is always to reduce inflammation and improve your quality of life.
Adalimumab-adaz works by blocking TNF-alpha, a protein that acts like a messenger in your immune system. When you have an autoimmune condition, your body produces too much TNF-alpha, which triggers widespread inflammation.
Think of TNF-alpha as an overzealous security guard that keeps sounding false alarms. This medication essentially tells that security guard to calm down, reducing the inflammatory response that's causing your symptoms.
This is considered a strong, targeted medication because it specifically blocks one pathway in your immune system rather than suppressing your entire immune response. However, because it does affect your immune system, it can make you more susceptible to infections, which is why your doctor will monitor you closely.
The effects typically begin within a few weeks to a few months of starting treatment. Some people notice improvements sooner, while others may need several months to experience the full benefits.
Adalimumab-adaz is given as a subcutaneous injection, meaning it goes into the fatty tissue just under your skin. You'll likely start with a loading dose, followed by regular maintenance injections every other week.
Your healthcare provider will teach you how to inject the medication yourself, or a family member can learn to help you. The injection sites typically rotate between your thigh and stomach area, staying at least one inch away from your navel.
Here's what you need to know about taking your medication properly:
You can take this medication with or without food, as it doesn't affect absorption. The timing of your injection doesn't need to coincide with meals, but try to inject it around the same time every two weeks to maintain consistent levels in your system.
The duration of treatment with adalimumab-adaz varies greatly depending on your specific condition and how well you respond to the medication. Most people with autoimmune conditions need long-term treatment because these are typically chronic conditions that require ongoing management.
Your doctor will regularly assess your response to the medication, usually every 3-6 months initially, then potentially less frequently once your condition stabilizes. They'll look at factors like symptom improvement, laboratory markers of inflammation, and any side effects you might be experiencing.
Some people may need to continue this medication for years, while others might be able to reduce the frequency or switch to a different treatment if their condition improves significantly. The key is working closely with your healthcare team to find the right balance between controlling your symptoms and minimizing potential risks.
Never stop taking adalimumab-adaz suddenly without consulting your doctor, even if you're feeling better. Stopping abruptly can lead to a flare-up of your underlying condition, which might be more difficult to control than before.
Like all medications that affect your immune system, adalimumab-adaz can cause side effects, though many people tolerate it well. Understanding what to expect can help you recognize when something needs medical attention versus normal, manageable effects.
The most common side effects are usually mild and often improve as your body adjusts to the medication:
More serious side effects require immediate medical attention, though they're less common. These occur because the medication affects your immune system's ability to fight infections and detect abnormal cells:
Rare but serious side effects include reactivation of hepatitis B (if you've had it before), certain types of cancer, and severe allergic reactions. Your doctor will screen you for these risk factors before starting treatment and monitor you throughout.
Adalimumab-adaz isn't suitable for everyone, particularly those with certain infections or immune system conditions. Your doctor will carefully review your medical history and current health status before prescribing this medication.
You should not take adalimumab-adaz if you currently have an active, serious infection of any kind. This includes bacterial, viral, or fungal infections that your body is actively fighting, as the medication could make these infections worse or harder to treat.
Other important conditions that may prevent you from taking this medication include:
Your doctor will also be especially cautious if you have a history of cancer, recurring infections, diabetes, or liver disease. These conditions don't necessarily prevent you from taking the medication, but they require closer monitoring and potentially modified treatment plans.
Adalimumab-adaz is marketed under the brand name Hyrimoz in the United States. This biosimilar was developed by Sandoz and approved by the FDA as a lower-cost alternative to the original adalimumab medication.
You might also hear healthcare providers refer to it by its generic name, adalimumab-adaz, where the "adaz" suffix helps distinguish it from other adalimumab biosimilars on the market. Different countries may have different brand names for the same medication.
When discussing your medication with pharmacists or other healthcare providers, it's helpful to mention both the brand name (Hyrimoz) and the generic name (adalimumab-adaz) to ensure everyone is referring to the same medication.
Several alternatives exist if adalimumab-adaz doesn't work well for you or if you experience significant side effects. Your doctor might consider other TNF blockers, which work similarly but have different dosing schedules or side effect profiles.
Other TNF blocker alternatives include etanercept (Enbrel), infliximab (Remicade), certolizumab (Cimzia), and golimumab (Simponi). Each has slightly different characteristics in terms of how often you take them and how they're administered.
Beyond TNF blockers, newer categories of medications target different parts of the immune system:
The choice of alternative depends on your specific condition, how you responded to previous treatments, your lifestyle preferences, and your individual risk factors. Your doctor will work with you to find the most appropriate option if adalimumab-adaz isn't the right fit.
Adalimumab-adaz is designed to be just as effective as Humira (the original adalimumab), but with potentially lower costs. Both medications contain the same active ingredient and work in essentially the same way to reduce inflammation.
The FDA requires biosimilars like adalimumab-adaz to demonstrate that they're highly similar to the original medication in terms of safety and effectiveness. This means you should expect similar results whether you're taking Humira or adalimumab-adaz.
The main advantages of adalimumab-adaz over Humira often relate to cost and accessibility. Because biosimilars typically cost less than the original medication, they may be more affordable for you or preferred by your insurance company.
Some people do notice slight differences in tolerability or injection site reactions when switching between different adalimumab products, but these are usually minor. If you're currently doing well on Humira, your doctor might suggest staying with what works, while new patients might start with the biosimilar option.
Is adalimumab-adaz safe for pregnancy?
Adalimumab-adaz crosses the placenta and can affect your developing baby's immune system. If you're pregnant or planning to become pregnant, discuss this thoroughly with your doctor, as they'll need to weigh the benefits of controlling your autoimmune condition against potential risks to your baby.
Many women with autoimmune conditions do continue adalimumab during pregnancy when the benefits outweigh the risks. However, your doctor might adjust your treatment plan or suggest alternative approaches. If you take adalimumab during pregnancy, your baby may need special monitoring for infections after birth.
What should I do if I accidentally use too much adalimumab-adaz?
If you accidentally inject more adalimumab-adaz than prescribed, contact your healthcare provider immediately, even if you feel fine. While overdoses are rare with this medication, taking too much could increase your risk of serious infections or other complications.
Don't try to "balance out" an overdose by skipping your next dose. Instead, let your doctor determine the best course of action, which might include more frequent monitoring or adjusting your next injection schedule.
What should I do if I miss a dose of adalimumab-adaz?
If you miss a dose, take it as soon as you remember, then continue with your regular schedule. However, if it's almost time for your next scheduled dose, skip the missed dose and resume your normal routine.
Don't take two doses close together to make up for a missed dose. If you're unsure about timing, contact your healthcare provider for guidance. Missing occasional doses usually won't cause immediate problems, but try to maintain consistency for the best results.
When can I stop taking adalimumab-adaz?
You should only stop taking adalimumab-adaz under your doctor's guidance, even if you're feeling much better. Autoimmune conditions are typically chronic, meaning they require ongoing management to prevent flare-ups.
Your doctor might consider reducing the frequency of injections or stopping the medication if your condition has been stable for an extended period, but this decision should always be made together. Stopping too early often leads to symptom recurrence, sometimes more severely than before treatment.
Can I drink alcohol while taking adalimumab-adaz?
Moderate alcohol consumption is generally acceptable while taking adalimumab-adaz, but discuss your drinking habits with your doctor. Since both alcohol and this medication can affect your liver and immune system, your doctor might recommend limiting alcohol intake.
If you also take other medications like methotrexate alongside adalimumab-adaz, alcohol restrictions might be more important. Your healthcare provider can give you specific guidance based on your complete treatment plan and overall health status.
6Mpeople
Get clear medical guidance
on symptoms, medications, and lab reports.